I've been keeping a Word document with every hopeful thing I can find, and Frequency Therapeutics is one of the only developments keeping me going right now. Sorry to repeat previous info but this is my summary of very encouraging things:
- The $32 million funding round. That's a pretty large boost and I think that they're already using that money to take the PCA platform further than hearing treatments is perhaps no bad sign: in fact, that really indicates efficacy.
- The Boston Globe reporting that their goal is to get a treatment on the market "in the next few years."
- They've been in "stealth mode" for 18 months, so must be onto something strong with this sudden flurry of publicity
- John LaMattina being appointed as Senior Advisor to the CEO. He had several top jobs at Pfizer, the largest pharmaceutical company on the planet. LaMattina has already helped them "
accelerate" development of their product candidates. He says: "The team has made
remarkably rapid progress"
- Robert Langer's reputation. "When MIT's Langer – who has launched dozens of companies and is said to be the world's most-cited engineer – is involved with a startup, he isn't usually looking to make a small change in a scientific field. '
Disruptive is the opposite of incremental,' he told us.
'Incremental change certainly happens, but fundamental changes – they're much rarer. I think that's what Frequency could be.'"
http://www.drugdeliverybusiness.com/stem-cell-therapy-reverse-hearing-loss/
I also saw this comment under the Globe piece: 'I have been working with deaf people in the academic world for twenty years and have heard Dr. Langer speak on a number of occasions. I regard him as a latter-day Edison, and if he is behind this effort it is bound to succeed!"